Form 8-K - Current report:
SEC Accession No. 0000914062-13-000105
Filing Date
2013-03-05
Accepted
2013-03-05 09:00:43
Documents
2
Period of Report
2013-03-05
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K galectin8k30513.htm 8-K 27590
2 PRESS RELEASE galectin8k30513ex99.htm EX-99.1 12122
  Complete submission text file 0000914062-13-000105.txt   40907
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 13663967
SIC: 2834 Pharmaceutical Preparations